Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial. Pract Radiat Oncol, 10(2), e82-e90. presented at the 2020 Mar - Apr. doi:10.1016/j.prro.2019.09.016. (2020).
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study. Cancer, 123(15), 2850-2859. presented at the 2017 Aug 01. doi:10.1002/cncr.30665. (2017).
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery. BJU Int, 115(3), 419-29. presented at the 2015 Mar. doi:10.1111/bju.12789. (2015).